NeuroPace (NPCE) Net Cash Flow (2020 - 2026)
NeuroPace's (NPCE) quarterly Net Cash Flow came in at -$6.2 million in Q1 2026, down 145.56% year-on-year from $13.6 million in Q1 2025, and down 695.66% quarter-over-quarter from $1.0 million in Q4 2025.
NeuroPace (NPCE) Net Cash Flow (2020 - 2026) Analysis & Trends
NeuroPace's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 145.56% year-over-year to -$6.2 million in Q1 2026; TTM through Mar 2026 was -$11.5 million, a 181.9% decrease from a year earlier, with the FY2025 full-year figure at $8.3 million, up 280.56% from the prior year.
- Net Cash Flow retreated to -$6.2 million in Q1 2026 per NPCE's latest filing, from $1.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $13.6 million in Q1 2025 and bottomed at -$11.7 million in Q1 2022.
- The 5-year median for Net Cash Flow is $35000.0 (2022), against an average of -$214882.4.
- Across the five-year window, Net Cash Flow soared 5225.71% in 2023 and tumbled 4475.65% in 2024, its largest moves.
- Year by year, Net Cash Flow stood at $886000.0 in 2022, then surged by 846.05% to $8.4 million in 2023, then sank by 122.56% to -$1.9 million in 2024, then surged by 154.89% to $1.0 million in 2025, then slumped by 695.66% to -$6.2 million in 2026.
- Per Business Quant, the three latest NPCE Net Cash Flow figures stand at -$6.2 million (Q1 2026), $1.0 million (Q4 2025), and -$2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.18 Mn |
| Mar 31, 2026 | -6.18 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Jun 30, 2025 | -4.14 Mn |
| Jun 30, 2025 | -4.14 Mn |
| Mar 31, 2025 | 13.57 Mn |
| Mar 31, 2025 | 13.57 Mn |
| Dec 31, 2024 | -1.89 Mn |
| Dec 31, 2024 | -1.89 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | -182,000.00 |
| Jun 30, 2024 | -182,000.00 |
| Mar 31, 2024 | -5.03 Mn |
| Mar 31, 2024 | -5.03 Mn |
| Dec 31, 2023 | 8.38 Mn |
| Dec 31, 2023 | 8.38 Mn |